ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
6 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
73 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
73
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
73 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
73
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
49 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
30 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
49 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
43 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
43
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
antibody
|
460 |
139K |
8 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
460
|
139K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
41 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
41
|
|
Charts
|
MSB |
Re:
chart
|
|
antibody
|
32 |
14K |
21 |
17/04/24 |
17/04/24 |
Charts
|
32
|
14K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
29 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
20 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
23 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
29 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
antibody
|
273 |
115K |
12 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
273
|
115K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
15 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
26 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
32 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
9.5K |
2.8M |
9 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
32 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
15 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
32 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
antibody
|
133 |
46K |
11 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
46K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
54 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
54
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
22 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech $6.4m Capital Raising
|
|
antibody
|
362 |
106K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
362
|
106K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech $6.4m Capital Raising
|
|
antibody
|
362 |
106K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
362
|
106K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
42 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
46 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
46
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
111 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
111
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
antibody
|
460 |
139K |
7 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
460
|
139K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Share consolidation
|
|
antibody
|
5 |
1.8K |
8 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5
|
1.8K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
69 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
69
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
antibody
|
551 |
200K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
551
|
200K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
antibody
|
554 |
224K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
554
|
224K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
16 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
113 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
113
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
37 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
37
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
5 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
186 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
186
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
30 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
60 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
60
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.1K |
2.5M |
22 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
antibody
|
551 |
200K |
9 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
200K
|
9
|
|